ISPE 2026 Annual Meeting – Two Oral Presentations for Mounya and Laetitia
Recognition for scientific excellence in pharmacoepidemiology
The International Society for Pharmacoepidemiology 2026 Annual Meeting will take place in Milan from August 31 to September 2, 2026, under the theme Unlocking the Power of Pharmacoepidemiology to Improve Patient Health. This leading international event will bring together researchers, clinicians, methodologists, regulatory authorities, and experts from around the world to discuss major challenges and emerging solutions in modern pharmacoepidemiology.
In a context marked by the rapid expansion of healthcare data and real-world evidence (RWE), the meeting will focus on generating robust evidence and translating it into clinical decision-making, regulatory assessment, risk management, health communication, and public health policies. The scientific program will include keynote lectures, plenary sessions, workshops, symposia, and networking opportunities designed to foster interdisciplinary collaboration.
On this occasion, the Epilogy team will be highlighted with the acceptance of two abstracts for oral presentation:
Risk of Herpes Zoster among Patients with Immune-Mediated Inflammatory Diseases Initiating Biologic or Targeted Synthetic Therapies: A Nationwide Cohort Study
Risk of Major Cardiovascular Events (MACEs) in Patients with Psoriasis, Psoriatic Arthritis and/or Other Forms of Spondyloarthritis: a Cohort of 72,291 Biologic New-Users
This double selection reflects the scientific excellence of the Epilogy team and its growing contribution to international research in pharmacoepidemiology, particularly in the evaluation of treatment safety and comorbidities associated with chronic inflammatory diseases. Congratulations Mounya and Laetitia!